News Focus
News Focus
Followers 48
Posts 5414
Boards Moderated 0
Alias Born 04/30/2005

Re: Gernee20 post# 293322

Tuesday, 01/19/2021 1:25:40 PM

Tuesday, January 19, 2021 1:25:40 PM

Post# of 517607
Excellent post, Gernee20.

*********************************************************

"Would you rather run 2 separate trials, a phase 2 and then a phase 3, or run one pivotal ph2/3? The fda has already cleared them to do this for 2 new indications with unmet needs. I haven’t seen this happen before. I’m guessing you have? The way I see it, as a long investor here, this is a very positive development which should cut out 18-36 months of development time and save the company millions of dollars. I’m all for anything that shortens development time and saves cash.

I know the original poster suggested skipping ph2, and jumping right to a ph3. I responded because Anavex is doing the next best possible thing, running 1 trial to get approval which I think was the point of the original poster
.
"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News